Citius Pharmaceuticals Financial Health

Short Term Liabilities: CTXR's short term assets ($44.6M) exceed its short term liabilities ($4.5M).

Long Term Liabilities: CTXR's short term assets ($44.6M) exceed its long term liabilities ($6.0M).

Debt Level: CTXR is debt free.

Reducing Debt: CTXR has no debt compared to 5 years ago when its debt to equity ratio was 0.8%.

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: CTXR has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: CTXR has sufficient cash runway for 1.3 years if free cash flow continues to reduce at historical rates of 38.5% each year.

• Healthy companies in the Pharmaceuticals & Biotech industry.